Bio-Rad Laboratories (NYSE:BIO.B) Sees Large Volume Increase – Here’s What Happened

Bio-Rad Laboratories, Inc. (NYSE:BIO.B) shares saw unusually-strong trading volume on Wednesday . Approximately 100 shares traded hands during trading, an increase of 1,329% from the previous session’s volume of 7 shares.The stock last traded at $312.75 and had previously closed at $310.70.

Bio-Rad Laboratories Stock Performance

The firm has a market cap of $8.44 billion, a P/E ratio of -12.87 and a beta of 1.01. The company has a debt-to-equity ratio of 0.18, a current ratio of 5.44 and a quick ratio of 3.94. The stock’s 50 day moving average is $310.78 and its two-hundred day moving average is $284.15.

Bio-Rad Laboratories (NYSE:BIO.B) last posted its earnings results on Wednesday, October 29th. The company reported $2.26 EPS for the quarter. Bio-Rad Laboratories had a positive return on equity of 4.19% and a negative net margin of 26.43%.The business had revenue of $653.00 million during the quarter.

Bio-Rad Laboratories Company Profile

Bio-Rad Laboratories, Inc is a global provider of innovative products and systems that serve the life science research and clinical diagnostics markets. The company operates through two primary segments: Life Science, which delivers instruments, consumables and software for research applications, and Clinical Diagnostics, which offers quality control materials and reagent systems for blood typing, immunology and molecular testing. Bio-Rad’s product portfolio supports a wide range of applications, including protein analysis, gene expression, cell biology and digital PCR.

In the Life Science segment, Bio-Rad develops and markets technologies such as electrophoresis and imaging systems, chromatography instruments, laboratory consumables and software platforms that streamline experimental workflows.